Jane Grogan, Biogen: “An Inside Look at R&D at Biogen”

Jane Grogan is Executive VP and Head of Research at Biogen, the 12th largest biotech in the world by market cap and the oldest independent biotech company on the East Coast. Biogen has FDA-approved medicines for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Friederich’s ataxia, multiple sclerosis, postpartum depression, and spinal muscular atrophy. Biogen applies deep understanding of human biology and leverages different modalities to advance first-in-class treatments and is currently focused on further expanding its pipeline in rare disease and immunology. Join us for an inside look at Biogen’s R&D, the challenges it faces and its approaches to solving them, and lessons Jane has learned in her career, including 15 years at Genentech.